Evidence map›Paper›PMID 28487695›Full record

ArticleFrontiers in immunology2017

Regulatory T Cells and Pro-inflammatory Responses Predominate in Children with Tuberculosis.

Elizabeth Whittaker, Mark Nicol, Heather J Zar, Beate Kampmann

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Frontiers in molecular biosciences · 2022
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Tuberculosis susceptibility and protection in children.The Lancet. Infectious diseases · 2019
    Review
  14. Regulatory T Cells inFrontiers in immunology · 2019
    Review
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Elizabeth WhittakerAcademic Department of Paediatrics, Imperial College London, London, UK.
Mark NicolUCT Faculty of Health Sciences, Division of Medical Microbiology, Department of Clinical Laboratory Sciences, Institute of Infectious Disease and Molecular Medicine, Cape Town, South Africa.
Heather J ZarMRC Unit of Child and Adolescent Health, University of Cape Town, Cape Town, South Africa.
Beate KampmannAcademic Department of Paediatrics, Imperial College London, London, UK.
Wellcome Centre for Infectious Diseases Research in Africa · ZAImperial College London · GBRed Cross War Memorial Children's Hospital · ZA

Funding

Medical Research Council MC_EX_MR/K011944/1Medical Research Council MC_EX_MR/P024270/1
6 · The paper itself

Abstract

backgroundFollowing infection with

objectiveTo comprehensively analyze key immune responses to mycobacteria between HIV-negative children with extrapulmonary TB (EPTB) compared to children with pulmonary TB (PTB) or healthy controls.

methodsWhole blood was stimulated

resultsSeventy-six children with TB disease (48 with PTB and 28 with EPTB) and 83 healthy controls were recruited to the study. The frequency of CD4

conclusionIn children with TB disease, a predominantly immune regulatory state is present. These immune findings do not distinguish between children with PTB and EPTB at the time of diagnosis. Following treatment, these inflammatory responses recover in PTB, suggesting that the effect is disease specific rather than due to an underlying host defect.

Indexed as

extrapulmonarymycobacterial immunitypediatricregulatory T cellstuberculosis

Identifiers

PMID28487695
PMCPMC5403917
OpenAlexW2609266603

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.